Eliem Therapeutics, Inc. (ELYM) News

Eliem Therapeutics, Inc. (ELYM): $7.41

0.03 (-0.40%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ELYM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#46 of 360

in industry

Filter ELYM News Items

ELYM News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest ELYM News From Around the Web

Below are the latest news stories about ELIEM THERAPEUTICS INC that investors may wish to consider to help them evaluate ELYM as an investment opportunity.

Eliem Therapeutics (NASDAQ:ELYM) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | September 28, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!

William White on InvestorPlace | July 21, 2023

Eliem (ELYM) to Explore Strategic Options, Stock Rises 6%

Eliem (ELYM) announces its decision to halt its Kv7 development program in its quest to explore strategic alternatives. The stock of the company rises 6% in response on Thursday.

Yahoo | July 21, 2023

Why Is BioSig Technologies (BSGM) Stock Up 19% Today?

BioSig Technologies (BSGM) stock is rising higher on Thursday as subsidiary BioSig AI Sciences joins Nvidia's (NVDA) Inception program.

William White on InvestorPlace | July 20, 2023

Why Is Discover Financial (DFS) Stock Down 13% Today?

Discover Financial (DFS) stock is falling on Thursday after the financial services company revealed it's undergoing a regulatory review.

William White on InvestorPlace | July 20, 2023

Why Is Eliem Therapeutics (ELYM) Stock Up 6% Today?

Eliem Therapeutics (ELYM) stock is taking off on Thursday after the biotechnology company announced plans to explore strategic alternatives.

William White on InvestorPlace | July 20, 2023

Why Is Netcapital (NCPL) Stock Down 42% Today?

Netcapital (NCPL) stock is dropping on Thursday after the fintech company announced the pricing of a public share offering.

William White on InvestorPlace | July 20, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning!

William White on InvestorPlace | July 20, 2023

Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

SEATTLE and CAMBRIDGE, United Kingdom, July 20, 2023 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM) today announced that it has completed a review of its business, including the status of its programs, resources, and capabilities, and has made the determination to halt further development of its Kv7 program and to conduct a comprehensive exploration of strategic alternatives focused on maximizing shareholder value. Eliem has engaged Leerink Partners to act as a strategic advisor in

Yahoo | July 20, 2023

Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights

Presented initial preclinical data from ETX-123, Eliem's lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed mechanism of action on neuronal excitability Additional preclinical data updates for ETX-123 expected in 2023 SEATTLE and CAMBRIDGE, United Kingdom, May 11, 2023 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychi

Yahoo | May 11, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!